GOG3035 ChemoImmunotherapy PTXCBDCAOvaRex v chemo PTXCBDCAPbo w adv EO FTP ca
Full Title:
A Phase 3 DoubleBlind PlaceboControlled Multicenter Clinical Study comparing ChemoImmunotherapy PaclitaxelCarboplatinOregovomab versus Chemotherapy PaclitaxelCarboplatinPlacebo in Patients with Advanced Epithelial Ovarian Fallopian Tube or Peritoneal Carcinoma
Status:
OPEN TO ACCRUAL
Protocol Number:
2009075090
Principal Investigator:
Phase:
III
Prevention or Control:
Age Group:
Scope:
Disease Site(s):
Ovary
National Institutes of Health - ClinicalTrials.gov NCT Number: NCT04498117